AMGN Latest Headlines

Amgen Advances Leukemia Strategy With Completed Blinatumomab Study in Japan

at www.tipranks.com (Thu, 8-Jan 11:31 AM)

Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs

at www.benzinga.com (Wed, 7-Jan 1:45 PM)

Amgen Advances Early-Stage Obesity Candidate With New Injection Trial

at www.tipranks.com (Wed, 7-Jan 11:33 AM)

Amgen (AMGN) Receives a Buy from Piper Sandler

at www.tipranks.com (Wed, 7-Jan 7:27 AM)

Citi Sticks to Their Hold Rating for Amgen (AMGN)

at www.tipranks.com (Wed, 7-Jan 6:47 AM)

Amgen upgraded to buy at UBS on potential of MariTide, olpasiran

at seekingalpha.com (Tue, 6-Jan 5:09 PM)

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!

at www.tipranks.com (Tue, 6-Jan 11:57 AM)

M&A News: Amgen Stock (AMGN) Brightens after $840M Capture of British Cancer-Fighting Biotech Dark Blue

at www.tipranks.com (Tue, 6-Jan 10:33 AM)

Amgen acquires Dark Blue Therapeutics for up to $840 million

at seekingalpha.com (Tue, 6-Jan 9:12 AM)

Amgen Expands Drug Discounts and Deepens U.S. Manufacturing Investments: Key Changes Ahead for Patients and Investors

Market Chameleon (Mon, 22-Dec 11:36 AM)

FDA Grants Full Approval to Amgen’s IMDELLTRA: Phase 3 Data Show 40% Reduced Risk of Death in Small Cell Lung Cancer

Market Chameleon (Thu, 20-Nov 8:24 AM)